03-07-2016 - 06-07-2016 32nd Annual Meeting of the European Society of Human Reproduction and Embryology - Helsinki, Finland
Over the past 30 years, the ESHRE Annual Meeting has grown to become a truly international event representing more than 100 different nationalities and with an attendance of around 9000 delegates.
The scientific committee has once again arranged a very interesting programme with invited sessions on different areas of human reproductive research and medicine designed to meet the interests of all participants. Precongress Courses will offer a wide range of topic, and the scientific and commercial exhibits will present the latest information in laboratory and clinical products.
04-05-2016 - 07-05-2016 9th World Congress of Perinatal Medicine in Developing Countries - Paraquay, Asuncion
This important World Congress will bring together the most experienced and talented experts in the field and share their concepts and knowledge. The advancing technology and complexity of practicing medicine required the valuable participation of the pharmaceutical, medical imaging and medical technology; we therefore look forward to have your support with the guarantee to deliver the highest quality event.
06-10-2014 Symposium (Expanded) carrier screening: possibilities and challenges - Holy Spirit College, Leuven
When both partners are identified as carriers of the same autosomal recessive disease, they have a 1-in-4 risk of having a child affected with this disease in each pregnancy. While screening during pregnancy is considered most practical, the preconception period is generally seen as the ideal timing, because it results in more reproductive options being available, with more time to make an informed decision. Currently, population-based carrier screening is typically performed for relatively common, single-gene recessive disorders associated with significant morbidity and reduced life-expectancy. Examples are carrier screening for cystic fibrosis (CF) (offered in countries including the United States, Australia, Italy, Israel) and ß-thalassemia (offered in e.g. Cyprus, Sardinia, Israel). Other examples include limited panels of disorders aimed at specific communities such as the Ashkenazi Jewish population, which have dramatically lowered the number of children affected with diseases such as Tay-Sachs.
In contrast to a diagnostic testing, for carrier screening - in the absence of a family or personal history of the disease - the tested mutations are usually restricted to the most frequent variants with known pathogenicity. With the introduction of new technologies, it is now possible to not only detect a much larger set of mutations, but also to simultaneously screen for many more diseases at a faster turnaround time for lower costs. Moreover, while most of the current screening programs are ethnicity-based, expanded carrier screening allows for screening all patients regardless of ethnicity, which increases equity and reduces the chance of stigmatization of ethnic groups. An increasing number of commercial laboratories, also in Europe, already offer panels for carrier screening for over 100 diseases. The expected near-future implementation of expanded panels in regular health care will pose a major challenge for physicians offering these tests. Responsible implementation of expanded carrier screening requires consideration of many technical, ethical, legal, and social questions. For example: which diseases and mutations to include? What are public and professional attitudes and preferences? How to optimize pre-test education, post-test counseling and facilitate informed decision-making?
10-11-2013 - 13-11-2013 Birth Defects and Disabilities in the Developing Countries - Cebu City, Philippines
The conference aims to:
· Examine issues, challenges, and strategies for strengthening national and sub-national systems for capturing reliable data as regards prevalence, mortality, short- and long-term impairment and economic costs related to birth defects and preterm birth, especially in low-resource settings
· Identify existing but underutilized opportunities to prevent birth defects and preterm births in lower-income countries
· Discover and develop strategies to reduce mortality and improve physical and developmental outcomes of newborns and children with a birth defect or with complications due to preterm birth
· Discuss recent research findings that can be translated in the immediate future to improve prevention, health promotion and care related to birth defects and preterm birth, especially in lower-income countries
· Recognize and coordinate the efforts of key stakeholders needed to advance prevention, care and health promotion related to birth defects and preterm births
22-04-2013 - 25-04-2013 Reproductive and Sexual Health - Denmark, Copenhagen
25-10-2012 - 26-10-2012 Haemglobinopathies and Rare Anaemias: Towards t...
04-10-2012 - 05-10-2012 Preconception Care and Health
04-10-2012 - 05-10-2012 2nd European Congress on Preconception Care and...
24-09-2011 - 27-09-2011 5th International Conference on Birth Defects a...
06-10-2010 - 09-10-2010 Preconception Care and Preconception Health